Clinical Trial Update: A Trial of Neuroprotection With ACTH in Acute Optic Neuritis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on neuroprotection with ACTH in acute optic neuritis for multiple sclerosis, terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• ACTH (adrenocorticotropic hormone)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Multiple Sclerosis | Phase 4 | Status: TERMINATED